Clinical Trial Detail

NCT ID NCT03283631
Title Intracerebral EGFR-vIII CAR-T Cells for Recurrent GBM
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gary Archer Ph.D.
Indications

malignant glioma

Therapies

EGFR-vIII CAR-T Cells

Age Groups: adult senior

No variant requirements are available.